XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,424,301 | -8.0% | 41,695 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $1,547,661 | +81014.3% | 40,199 | -24.6% | 0.00% | 0.0% |
| Q1 2023 | $1,908 | -5.6% | 53,307 | +4.0% | 0.00% | 0.0% |
| Q4 2022 | $2,022 | -99.9% | 51,280 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $1,818,000 | +34.9% | 50,360 | +13.7% | 0.00% | 0.0% |
| Q2 2022 | $1,348,000 | -14.1% | 44,311 | -11.0% | 0.00% | 0.0% |
| Q1 2022 | $1,570,000 | +20.0% | 49,797 | +18.9% | 0.00% | – |
| Q4 2021 | $1,308,000 | +192.0% | 41,884 | +43.0% | 0.00% | – |
| Q3 2021 | $448,000 | -55.0% | 29,298 | -45.2% | 0.00% | – |
| Q2 2021 | $995,000 | +214.9% | 53,454 | +203.0% | 0.00% | – |
| Q1 2021 | $316,000 | +62.9% | 17,643 | +40.0% | 0.00% | – |
| Q4 2020 | $194,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |